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ABSTRACT 
Introduction: Patients who have received radiation therapy due to oral cancers often 
present with complications such as salivary dysfunction, mucositis, soft tissue 
necrosis, infections and dental caries. The aim of this study was to investigate the 
antimicrobial properties of an experimental mouthrinse which also contains analgesic 
and anticaries compounds and can be used in the management of patients with oral 
cancers after radiation therapy. 
 
Methods: The experimental mouthrinse contained a mixture of 30% glycerine 
(antimicrobial agent), 7% potassium nitrate (analgesic) and 0.025% sodium fluoride 
(anticaries agent). The minimal inhibitory concentration (MIC) of these ingredients 
was tested against Candida albicans, Staphylococcus aureus and Streptococcus 
mutans over 24 hours at different concentrations. MICs of commercially available 
mouthrinses containing chlorhexidine digluconate (Corsodyl®) and fluoride with 
triclosan (Plax®) were also determined using the same organisms. All mouthrinses 
were then tested to determine the percentage kill over 1, 2, and 3 minutes. The costs 
of these mouthrinses were also compared.  
 
Results: The MICs for glycerine were 10%, 25% and 10% for C. albicans, S. aureus 
and S. mutans respectively. Potassium nitrate, sodium fluoride and alum did not show 
any antimicrobial effects. The MIC of Corsodyl® was <0.02 mg/ml for all the test 
organisms. The MIC for Plax was 0.02 mg/ml, <0.002 mg/ml and 0.005 mg/ml for C. 
albicans, S. aureus and S. mutans respectively. Combining glycerine, potassium 
nitrate and sodium fluoride into a mixture did not affect the antimicrobial properties 
of these constituents. The mixture killed 99.78%, 99.88% and 99.98% of C. albicans, 
61.74%, 70.64% and 85.09% of S. aureus and 91.72%, 99.47% and 99.99% of S. 
mutans after 1, 2 and 3 minutes respectively. Two percent chlorhexidine digluconate 
killed 98.98%, 99.97% and 99.99% of C. albicans, 95.83%, 99.68% and 99.97% of S. 
aureus and 99.98%, 99.96% and 99.99% of S. mutans after 1, 2 and 3 minutes 
respectively. Plax® killed 99.99% of C. albicans in one minute, 99.66%, 99.99% of S. 
aureus in 1 and 2 minutes respectively; and 99.89%, 99.96% and 99.99% of S. mutans 
in 1, 2 and 3 minutes respectively. The costs of similar amounts of the experimental 
mouthrinse, Corsodyl® and Plax® were R5.24, R30.00 and R10.00 respectively. 
 
Conclusion:  A mouthrinse effective in relieving oral symptoms in patients receiving 
radiation therapy needs to show some antimicrobial activity against in particular, C. 
albicans and S. mutans, whilst at the same time having a palliative effect. This study 
has shown that the experimental mouthrinse will fulfil these requirements. The 
experimental mouthrinse was found to be the cheapest in comparison to Corsodyl® 
and Plax®.  
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1 LITERATURE REVIEW 
1.1 Introduction 
Saliva comprises 99% water and 1% organic and inorganic components.  
Saliva modulates the oral flora by favouring the attachment and proliferation 
of certain microorganisms and promoting the clearance of others.  Saliva also 
protects the oral tissues from dessication and exogenous insults from acids and 
degradative enzymes (Almstahl, Wikstrom and Groenink, 2001).  
The level of radiation necessary to destroy malignant cells ranges from 40-70 
Gy.  This dosage is delivered directly to the tumour and surrounding tissues.  
The salivary tissue is sensitive to radiation at a dosage greater than 30Gy 
(Cassolato and Turnbull, 2003) and the degree of destruction of glandular 
tissue is dose related.  Radiation of 45Gy to the head and neck field will result 
in irreversible salivary gland destruction and xerostomia (Rhodus and 
Bereuter, 2000). 
 
 It has been reported that after just five radiation treatments at a dose of 
200cGy per day, the salivary rate decreased by up to 57 per cent (Dreizen, 
1977 cited by Garg and Malo, 1997).  
 
In addition, drugs used to treat cancer can cause a thickening of saliva 
inducing a dry feeling and contributing to impairment of salivary function.  
The following complications are really the sequelae of salivary dysfunction: i) 
oral-pharyngeal  candidiasis, ii) xerostomia, iii) mastication problems and poor 
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nutritional intake, iv) gingivitis and traumatic oral lesions v) dental caries and 
halitosis and vi) poorly fitting prostheses (Cohen-Brown and Ship, 2004).  
 
1.1.1 Oral candidiasis 
Complications of salivary gland dysfunction and the reduced immunity 
resulting from cancer therapy may give rise to opportunistic infections such as 
oral candidiasis caused by Candida albicans (Toljanic 1996 cited by 
Silverman 1999; Epstein, et al., 1998).  Salivary histamines are the key 
components of the non-immune host defence system of the oral cavity (Baev, 
Rivetta and Vylkova, 2004).  Histatin 5 kills pathogenic Candida albicans at 
physiological concentrations of 15-30µm (Xu and Levine 1991 cited by Baev 
et al. 2004), therefore when histamines are compromised as in patients where 
there is salivary dysfunction, Candida albicans is over produced. Candidiasis 
is usually painful and needs treatment, as untreated candidiasis can lead to 
oropharyngeal and systemic candidiasis. 
  
1.1.2  Xerostomia 
Xerostomia is one of the major side effects of radiation therapy for head and 
neck malignancies.  Exposure of the major salivary glands to the field of 
ionising radiation induces fibrosis, fatty degeneration, acinar atrophy and 
cellular necrosis within glands.  The serous acini appear to be more sensitive 
than the mucinous acini.  Recovery of adequate saliva for oral comfort and 
function may take up to 12 months (Silverman, 1999). 
The xerostomic patient has mucosa that is dry and sticky, and saliva with a 
stringy or foamy consistency.  The normal moist appearance of the oral cavity 
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is often replaced with a thin, pale and cracked appearance that is more 
susceptible to gingivitis and bleeding.  The patients experience increased 
problems with tasting, speaking, chewing and swallowing.  
 
1.1.3  Mastication problems and poor nutritional intake   
Normally patients present with painful mucositis, loss of taste and partial 
xerostomia, all of which lead to a lack of desire or frank inability to eat; this 
results in weight loss and malnutrition (Isenring, Capra and Bauer, 2004) and 
the quality of life is negatively affected (Epstein, Robertson and Emerton, 
2001).  A resultant weight loss tends to produce weakness, inactivity and 
susceptibility to infection. 
 
1.1.4   Dental caries and halitosis 
Patients who have not shown any degree of caries activity for years may 
develop dental decay after irradiation.  The cervical areas are most affected. 
This condition appears to be due to the lack of saliva as well as to changes in 
salivary chemical composition (Epstein, et al., 1996).  Radiation caries may 
develop because of a shift in oral flora to a more cariogenic flora (S. mutans) 
or because of a decreased clearance of carbohydrates and acids, and/or a 
reduced ability to buffer acids. 
  
1.2   Mucositis and soft tissue necrosis 
Most cancer therapies are designed to act on rapidly reproducing cells.  The 
cells that line the gastrointestinal tract from the mouth to the rectum are 
especially vulnerable (Velez, Tamara & Mintz, 2004).  Mucositis is an early 
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effect of radiation and results from mitotic death of the basal cells of the oral 
epithelium.  It usually appears two weeks after initiation of radiotherapy.  Oral 
mucositis presents with erythema accompanied by dryness, pain and burning 
symptoms. Soft tissue necrosis usually presents itself as ulceration of the 
mucosa, is usually painful and optimal hygiene is required.  
 
1.3   Treatment currently prescribed 
` After briefly looking at the complications that are experienced by patients that 
have undergone radiation of the head and neck to treat head and neck cancer, 
the treatment modalities that are available will be reviewed.     
 
 
Table 1.1 shows therapies that have been used in the treatment of radiation-
induced and chemotherapy-induced mucositis, though some reports 
demonstrate little evidence supporting the effectiveness of the corresponding 
interventions (Velez, et al. 2004). 
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Table 1.1  
Therapies that deal with specific problems associated with head and neck 
radiotherapy 
Therapy Dose Reference 
1. Saliva production  
  
Pilocarpine hydrochloride 5 mg tablet 3 or 4 times 
per day for 90 days 
Cohen-Brown and Ship, 
2004; Cassolato and 
Turnbull, 2003; Porter, 
Scully and Hegarty 2004;   
2. Saliva substitutes 
  
Buffered solution of 
glycerine and water 
20ml of 4% sol of methyl 
cellulose, 10ml of 
glycerine and 1 drop of 
lemon oil  
Cassolato and Turnbull, 
2003 
3. Mucosal coating agents   
Milk of magnesia  Andrews and Griffiths 
2001; Garg and Malo, 
1997; 
4. Antifungal agents 
  
Systemic-Fluconazole 
                 
                Ketoconazole 
Topical -  Nystatin-oral 
                suspension  
                 
                Nystatin-lozenge   
100mg suspension, rinse 
then swallow daily 
200mg suspension 
100,000units/ml, rinse 
with 5ml for 2min then 
swallow 4x/day 
Dissolve 1 lozenge in the 
mouth 5x/day 
Epstein, Gorsky and 
Caldwell, 2002 
 
Silverman, 1999  
Andrews and Griffiths, 
2001 
 
 
Cohen-Brown and Ship, 
2004 
5. Antibacterial agents   
Chlorhexidine  Hancock, Epstein and 
Sadler, 2003 
6. Topical anaesthetic or 
analgesics 
  
Benzydamine 
hydrochloride. 
 
0.15% oral rinse 15ml 
every 2 hr and spit 
 
Scully, Epstein and Sonis, 
2004; Velez et al., 2004 
7. Fluoride   
Sodium flouride 1.1% sodium fluoride 
Put in trays for 5-10 min-
spit out excess 
Garg and Malo, 1997 
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• Sialogogues: Pilocarpine is the only agent approved by the FDA for radiation-
induced xerostomia (Chambers, Garden and Kies, 2004).  
• Saliva substitues: Commercially produced artificial saliva can be used but 
Visch, Gravenmade and Schaub (1986) showed that about one-third of the 
post-radiation patients did not benefit from saliva substitutes.  Also it has been 
shown that lemon-based saliva substitutes are potentially erosive to enamel 
when used frequently (Smith et al. 2001 cited by Cassolato and Turnbull, 
2003).  
• Antifungal medication: Topical therapy (Nystatin, Miconazole, and 
Clotrimazole) is generally effective in controlling low-grade uncomplicated 
mucosal candidiasis. In cases of severe oral-pharyngeal candida infection, 
topical therapy in conjuction with systemic therapy may ensure a lower 
systemic dose and shorten the duration of the systemic antifungal therapy 
(Epstein, 2002).     
• Chlohexidine: Chlorhexidine is a potent antimicrobial agent effective against 
both gram-negative and gram-positive bacteria and fungal organisms but a 
variety of studies (Feretti et al. 1990 cited by Andrews and Griffiths 2001; 
Epstein, 1992; Dodd, Larson and Dibble 1996; and Pitten et al. 2003) have 
shown that there was no difference in oral mucositis between the control and 
chlorhexidine groups of high dose radiotherapy patients.  It is thought that the 
chlorhexidine molecule binds to the negatively charged salivary mucins or 
glycoproteins rather than directly to the epithelial tissues.  The rapid 
development of xerostomia in radiotherapy patients deprives the oral 
epithelium of its usual salivary fluid coating, thereby diminishing the mucosal 
protective effect of chlorhexidine. 
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• Fluoride treatment: There is no one universally accepted protocol for the 
management of radiation caries, however the importance of fluoride is well 
recognised.  Recommended fluoride preparations contain 0.4 per cent stannous 
fluoride, 1.1 per cent sodium fluoride, 1.23 per cent sodium fluoride or 1.23 
per cent phosphate fluoride.  Patients are instructed to spread several drops of 
the fluoride gel into customised trays. The tray is then seated in the mouth and 
left in place for 5-10 minutes (Andrews and Griffiths, 2001).  Patients are 
encouraged not to drink or eat for one hour, so compliance can be a problem, 
as reported by Epstein, van der Meij and Emerton (1995) when only 43 per 
cent of patients reported using fluoride in custom trays daily.   
 
Oral care protocols should strive to maintain the integrity of the oral mucosa 
and lips, prevent caries and periodontal disease, alleviate oral discomfort and 
prevent or treat infectious complications.  The oral hygiene practices that have 
been advocated by various authors are largely empirically based and the 
optimal frequency of cleansing and mouth washing is questionable (Andrews 
and Griffiths, 2001).  Visch et al. (1986) concluded that about one-third of 
post-radiation patients gained no benefit from salivary substitutes.  To prevent 
or at least minimize post-radiation complications, oral hygiene must be 
maximal and a mouthrinse is essential.     
 
 
 8
1.4   The use of Mouthrinses 
1.4.1  Efficacy 
The use of mouthrinse has been indicated in a number of situations, such as as 
an adjunct to mechanical control of plaque build up (Quirynen et al. 1999); as 
a secondary prevention measure after oral surgery including periodontal 
therapy (Chandu et al. 2002); and as a plaque growth inhibitor (Charles et al. 
2004). 
Antiseptic mouthrinses have been broadly classified by Newbrun (1985) cited 
by Mandel (1988) in the following manner: a) phenolic compounds, b) 
quaternary ammonium compounds, c) oxygenating agents d) Bis-biguanides 
and e) antibiotics. 
 
An essential oil mouthrinse which is a mixture of thymol, eucalyptol, menthol 
and methylsalicylate has been shown to be more effective than an amine 
(stannous fluoride) mouthrinse in inhibiting the development of supragingival 
plaque over a 4-day period in vitro (Mandel 1988, Pan et al. 1999).  A 4-day 
plaque regrowth study compared the efficacy of a triclosan mouthrinse to that 
of an essential oil when the allocated rinse was the only method of oral 
hygiene, and found that the essential oil rinse produced a plaque reduction of 
50%, whilst the triclosan rinse produced a 45% reduction (Addy and 
Newcombe 1997). 
 
A meta-analysis of six-month studies of antiplaque and antigingivitis agents 
showed that essential oil and chlorhexidine mouthrinses were effective as both 
antiplaque and antigingivitis agents (Gunsolley, 2006). 
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Epstein, et al. (2002) studied the effect of fluconazole mouthrinses on oral 
candidiasis in postirradiation and transplant patients. They found complete 
symptomatic and clinical relief in 94% of the patients. They concluded that an 
oral rinse with fluconazole mouthrinse may be useful to manage patients with 
dry mouth and those who have difficulties in swallowing due to candidiasis.          
 
1.4.2  Chemicals used in mouthrinses 
1.4.2.1  Alum (Aluminium potassium sulphate) 
A number of investigations have been conducted to study the effect of 
aluminium salts on human oral flora and dental plaque.  In 1940 Henke (cited 
by Kleber and Putt, 1984) showed that 0.04% aluminium acetate and 0.25% 
aluminium formate decreased the amount of acid production in a saliva-
sucrose mixture by 43%.  Kleber et al. (1996) evaluated the effect of an alum 
mouthrinse on dental caries incidence in caries-susceptible children.  Their 
study demonstrated clinically that a daily rinse with alum mouthrinse inhibited 
dental caries development at least as effectively as home use of a fluoride 
dentifrice.     
 
1.4.2.2  Glycerine 
Some patients who have undergone radiation therapy may have developed a 
lowered salivary output and the quality of saliva may also have changed. 
Glycerine is used both as an humectant and as an antimicrobial agent.  
Kinnunen and Koskela (1991) showed that 10% hexylene glycol killed 
Candida albicans, Staphylococcus aureas and Streptococcus pyogenes in 
vitro.   
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1.4.2.3 Salt (NaCl) 
Salt is known to have some antifungal effect. Fan, Whitway and Shen (2005) 
showed that the central component of the osmoregulation pathway in Candida 
albicans is MAP Kinase and salt has been shown to interrupt that pathway. 
Saline solution mouthrinses are safe and economical and have been used in 
cancer populations (Daeffler 1981, Seglman 1977 cited by Dodd et al. 2003). 
 
1.4.2.4  Potassium nitrate    
Radiation therapy causes cell death not only of cancerous lesion but also of the 
surrounding oral tissues.  Toxic effects including cell death can be blocked by 
an elevated extra-cellular calcium or by an elevated external potassium (Baev 
et al. 2004). 
 
Potassium nitrate promotes pain control and healing by changing the resting 
membrane potential of nerves in, for example an ulcer, to zero or positive, 
preventing an action potential from taking place and inhibiting these nerves 
from emitting and conducting pain; this in turn inhibits the autonomic nerves 
from initiating an inflammatory tissue response.  The classic inflammatory 
response of histamines, bradykines, leukotrines, prostaglandins and 
oedematous fluid is thus not stimulated to bring inflammatory components to 
the ulcer lesion (Hodosh, Hodosh and Hodosh, 2004).   
 
1.4.2.5 Sodium fluoride 
Fluoride has protective effects on enamel by decreasing demineralization 
induced by S. mutans and by inhibition of bacterial metabolism (Van Loveren, 
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Buijs and ten Cate, 1993).  A study to evaluate the effectiveness of topical 
fluoride in reducing S. mutans  in healthy populations concluded that a daily 
rinse with 0.025% sodium fluoride provided enamel protection against S. 
mutans (Inaba et al. 2002).  Epstein et al. (1998) studied the relationship 
between fluoride, cariogenic oral flora and salivary flow rate during radiation 
therapy.  They found that cariogenic flora were suppressed when daily topical 
1.1% neutral sodium fluoride was used.     
 
1.4.2.6  Triclosan  
Triclosan is a broad spectrum antimicrobial agent developed for use in oral 
products.  It is effective against both gram negative and gram positive bacteria 
(Panagakos et al. 2005; Xu et al. 2005).  Triclosan is normally recommended 
for controlling plaque (Pizzo et al. 2006) and as an anti-inflammatory agent 
(Wara-aswapati et al. 2004).   
 
1.4.2.7 Chlorhexidine digluconate  
Chlorhexidine digluconate is normally given in a concentration of 0.2%. 
Various studies (McGaw and Belch, 1985; Epstein et al. 1992) showed that 
chlorhexidine gluconate can control oral candidiasis in cancer patients.  This 
mouthrinse is not ideal since it irritates the mucosa and discolours the tongue 
and teeth especially the interproximal surfaces (Ernst, Prockl and 
Willershausen, 1998).  It also affects the taste quality and intensity of sodium 
chloride, and the taste quality of sucrose (Helms et al. 1995).  Pitten et al. 
(2003) showed that cancer patients with chemotherapy-induced leukopenia did 
not benefit from a chlorhexidine based mouthrinse, instead they developed 
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severe mucositis when compared to the control group.  There was a clear 
microbial count reduction in the chlorhexidine based group as compared with 
the control group.    
 
1.5   Summary and conclusions 
The optimal care of many patients with oral tumours is a multidisciplinary 
effort that combines surgery, radiation therapy and or chemotherapy; 
postoperatively it may involve oral surgeons, periodontists and 
prosthodontists.  Hille, Shear and Sitas (1996) have shown that in South Africa 
3.4 per cent of all patients diagnosed with cancer had oral cancer.  The gender 
distribution was 1.8 per cent for females and 5.0 per cent for males.  From data 
collected from Johannesburg General Hospital there were at least 171 patients 
in 2001 and 161 patients in 2002 who received radiation, chemotherapy, 
surgery or surgery together with radiation to treat oral carcinoma. More recent 
data are unavailable. 
 
Patients who have received radiation therapy present with the following major 
complications: salivary dysfunction; mucositis, soft tissue necrosis; oral 
infection; and dental caries (figure 1.1).  The Prosthodontist normally is called 
upon to provide obturators and partial/complete dentures so that patients are 
able to speak or swallow properly while experiencing these complications.  At 
Wits Dental Hospital patients are normally referred from the Oncology unit, 
JHB hospital. On average 5 patients per week are referred after having had 
and/or whilst receiving radiation treatment. 
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Fig 1.1:  Intra-oral complications of patients undergoing radiotherapy 
treatment showing plaque accumulation, mucositis, buccal 
mucosal ulceration, and an oro-antral opening 
 
The microbial environment of the mouth may be subjected to change under the 
influence of various factors such as surgical removal of neoplasm and or the 
consequence of wearing post-surgical prostheses with obturators.  Wiekiewicz, 
Byzynska, Panek (2003) showed that more pathogenic bacterial flora were 
found on the obturators than in the post-surgical cavities. 
 
Almastahl, et al. (2003) analysed and compared the oral microbial flora in 
radiation therapy, primary Sjögren´s and neuroleptic patients.  They found a 
marked increased level of Lactobaccillus species and Candida albicans in the 
radiation therapy group. Lactobacillus is perpetuated by Streptococcus 
mutans.  C. albicans is the causative agent of oral candidiasis whereas S. 
mutans and Lactobacilli are implicated in dental caries.  Some infections in the 
circum-oral region are caused at least in part, by Staphylococcus aureus.  
These include angular cheilitis, osteomyelitis of the jaw and parotitis (Smith, 
Jackson and Begg, 2001).  
 14
Management of these patients is a major problem as there is currently no 
standard protocol.  It is known that mouthrinses can be of assistance, but the 
currently available commercial mouthrinses are expensive and have side 
effects (Hodosh, et al. 2004).  There is a need for a cheaper antimicrobial 
mouthrinse containing anticariogenic and palliative compounds.  Currently 
patients in the Wits unit are given Chlorhexidine digluconate, Daktarin gel and 
Paracetamol tablets. 
It was therefore decided to investigate a mouthrinse containing readily 
available and inexpensive agents that would in combination, have the 
properties desired in a mouthrinse for patients undergoing radiation therapy. 
 
1.6  Aims and Objectives 
1.6.1 Aim 
The aim of the study was to investigate the antimicrobial properties of salt, 
glycerine, alum, and a combination of these with potassium nitrate, and to 
compare the combination with two commercially available mouthrinses. 
 
1.6.2  Objectives 
The objectives were to: 
• Test the antimicrobial properties of each of the chemicals against S. 
mutans, S. aureus and C. albicans. 
• Compare a mouthrinse containing the agents with the commercially 
available mouthrinses Corsodyl® containing Chlorhexidine digluconate 
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(Group Laboratories (Pty) Ltd. Cape Town) and Plax® containing sodium 
fluoride and triclosan (Colgate and Palmolive (Pty) Ltd. Boksburg)  
2 METHODS AND MATERIALS 
    
2.1 Test organisms and preparation of inoculum 
Candida albicans ATCC 90028, Staphylococcus aureus ATCC 29213 and a 
clinical strain of Streptococcus mutans were used in this study. Sabouraudes 
dextrose broth (SAB) and Sabouraudes dextrose agar (SDA) were used to 
culture C. albicans. Nutrient broth (NB) and Tryptone agar (TA) were used to 
culture S. aureus. Nutrient broth and Blood agar (BA) were used to culture S. 
mutans. 
 
Cultures were plated on an appropriate agar plate (figure 2.1) and incubated at 
37oC for 48 hours. C. albicans and S. aureus were incubated aerobically 
whereas S. mutans was incubated under CO2.  Strains were further subcultured 
to ensure purity. 
 
Inoculums were prepared by suspending C. albicans in SAB, S. aureus and S. 
mutans in NB.  The optical densities of the inoculums were adjusted to 0.2 at 
620 nm which contained approximately 106 organisms per millilitre of 
suspension.  
 
 
Fig 2.1 Pure culture of test organism 
C. albicans 
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2.2 Test compounds  
Alum (Aluminium potassium sulphate), Glycerine (Hexylene glycol) and  
Potassium nitrate were purchased from Minema chemicals (South Africa). 
Sodium fluoride and Salt (Sodium chloride) were purchased from Merck 
chemicals (South Africa).  
 
2.2.1 Alum (Aluminium potassium sulphate) 
A stock solution of Alum was prepared by mixing 11.85g of Alum with 100ml 
of sterile distilled water which made 0.25M solution. Seven serial ¼ dilutions 
were prepared and eight concentrations including the stock solution were used 
in the study. In each dilution the concentration of Alum was calculated using 
the formula: 
Mole/4 X 3 = Concentration in Moles 
The final concentrations in each dilution are listed in table 2.1. 
           Table 2.1 Test concentrations of Alum                                                                                            
                                                                                                         
 
 
Alum 
1 
 
Stock 
solution 
 
2 
 
3ml 
of 
stock   
 
+ 
1ml 
H2O 
3 
 
3ml  
of 
conc. 
2   
 + 
1ml 
H2O 
4 
 
3ml  
of 
conc. 
3    
+ 
1ml 
H2O 
5 
 
3ml  
of 
conc. 
4    
+    
1ml 
H2O 
6 
 
3ml  
of 
conc. 
5 
+ 
1ml 
H2O 
7 
 
3ml  
of 
conc. 
6 
+ 
1ml 
H2O 
8 
 
3ml  
of 
conc. 
7 
+ 
1ml 
H2O 
 
 
Molar 
 
 
0.25 
 
 
0.188 
 
 
0.141 
 
 
0.106 
 
 
0.079 
 
 
0.059 
 
 
0.044 
 
 
0.033 
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2.2.2 Glycerine (Hexylene glycol) 
 
Various percentage solutions of glycerine were prepared by mixing it with 
sterile distilled water.  Eight concentrations including the stock solution were 
used in the study. The concentrations are shown in table 2.2. 
 
            Table 2.2 Test concentrations of glycerine 
 
 
 
Glycerine 
1 
 
Stock 
Solution 
 
2 
 
4ml 
stock 
+ 
1ml 
H2O 
3 
 
3.5ml 
stock 
+ 
2.5ml 
H2O 
4 
 
3ml 
stock 
+ 
2ml 
H2O 
5 
 
2.5ml 
stock 
+ 
2.5ml 
H2O 
6 
 
2ml 
stock 
+ 
3ml 
H2O 
7 
 
1.5ml 
stock 
+ 
3.5ml 
H2O 
8 
 
1ml 
stock 
+ 
4ml 
H2O 
 
 
Percentage
 
 
100% 
 
 
 
80% 
 
 
70% 
 
 
60% 
 
 
50% 
 
 
40% 
 
 
30% 
 
 
20% 
 
 
 
2.2.3 Sodium Chloride  
A stock solution of sodium chloride was prepared by mixing 36.1g with 100ml 
of sterile distilled water which made a 6M solution.  Seven serial ¼ dilutions 
were prepared and eight concentrations including the stock solution were used.  
In each dilution the concentration of sodium chloride was calculated using the 
formula:  Mole/4 X 3 = Concentration in Moles 
 
The final concentrations in each dilution are listed in table 2.3. 
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 Table 2.3 Test concentrations of Sodium Chloride 
 1 
 
Stock 
solution 
 
2 
 
3ml 
of 
stock  
+ 
1ml 
H2O 
3 
 
3ml of 
conc. 
2       
+ 
1ml 
H2O 
4 
 
3ml of 
conc. 
3 
 + 
1ml 
H2O 
5 
 
3ml of 
conc. 
4      
+ 
1ml 
H2O 
6 
 
3ml of 
conc. 
5  
+ 
1ml 
H2O 
7 
 
3ml of 
conc. 
6 
 + 
1ml 
H2O 
8 
 
3ml of 
conc. 
7 
+ 
1ml 
H2O 
 
 
Molar 
 
 
6 
 
 
4.5 
 
 
3.375 
 
 
2.531 
 
 
1.898 
 
 
1.424 
 
 
1.068 
 
 
0.801 
 
 
 
 
2.2.4 Potassium nitrate (KNO3) 
A stock solution of Potassium nitrate was prepared by mixing 7g of KNO3 
with 100ml of sterile distilled water to make a 7% solution. Seven serial ½ 
dilutions were prepared, and eight concentrations including the stock solution 
were used in the study.  In each dilution the concentration of Potassium nitrate 
was calculated.  
 
The final concentrations in each dilution are listed in table 2.4. 
             Table 2.4 Test concentrations of Potassium nitrate 
 
 1 
 
Stock 
solution 
 
2 
 
3ml 
of 
stock  
 
+ 
3ml 
H2O 
3 
 
3ml 
of 
conc. 
2      
+ 
3ml 
H2O 
4 
 
3ml 
of 
conc. 
3  
+ 
3ml 
H2O 
5 
 
3ml 
of 
conc. 
4    
 + 
3ml 
H2O 
6 
 
3ml 
of 
conc. 
5  
+ 
3ml 
H2O 
7 
 
3ml 
of 
conc. 
6  
+ 
3ml 
H2O 
8 
 
3ml 
of 
conc. 
7 
+ 
3ml 
H2O 
 
 
Percentage
 
 
7 
 
 
3.5 
 
 
1.75 
 
 
0.875
 
 
0.438
 
 
0.219 
 
 
0.109 
 
 
0.054 
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2.2.5 Sodium Fluoride (NaF) 
A stock solution of Sodium Fluoride was prepared by mixing 0.025g with 
100ml of sterile distilled water which made a 0.025% solution. Seven serial ½ 
dilutions of 0.025% were prepared, and eight concentrations including the 
stock solution were used.  
The final concentrations in each dilution are listed in table 2.5. 
 
            Table 2.5 Test concentrations of Sodium fluoride 
 
 1 
 
Stock 
solutio
n 
 
2 
 
3ml 
of 
stock 
 
+ 
3ml 
H2O 
3 
 
3ml 
of 
conc. 
2      
+ 
3ml 
H2O 
4 
 
3ml 
of 
conc. 
3  
+ 
3ml 
H2O 
5 
 
3ml 
of 
conc. 
4    
 + 
3ml 
H2O 
6 
 
3ml  
of 
conc. 
5  
+ 
3ml 
H2O 
7 
 
3ml  
of 
conc.  
6  
+ 
3ml 
H2O 
8 
 
3ml  
of 
conc. 
7 
+ 
3ml 
H2O 
 
 
Percentag
e 
 
 
0.025 
 
 
0.01
2 
 
 
0.00
6 
 
 
0.00
3 
 
 
0.00
1 
 
 
0.000
8 
 
 
0.000
4 
 
 
0.000
2 
 
 
 
 
2.2.6 Corsodyl (Chlorhexidine digluconate) 
 
Seven double dilutions of commercially available Corsodyl were prepared.  
The concentrations of chlorhexidine digluconate in each dilution are shown in 
table 2.6.  Eight concentrations including the stock solution were studied. 
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Table 2.6 Test concentrations of Corsodyl 
 1 
 
Stock 
solu. 
 
2 
 
5ml 
of 
stock 
 
+ 
5ml 
H2O 
3 
 
5ml  
of 
conc. 
2      
+ 
5ml 
H2O 
4 
 
5ml  
of 
conc. 
3 
+ 
5ml 
H2O 
5 
 
5ml  
of 
conc. 
4 
+ 
5ml 
H2O 
6 
 
5ml  
of 
conc 
5 
+ 
5ml 
H2O 
7 
 
5ml  
of 
conc. 
6 
+ 
5ml 
H2O 
8 
 
5ml  
of 
conc. 
7 
+ 
5ml 
H2O 
Chlorhe-
xidine 
digluconate 
mg/ml 
 
 
 
2 
 
 
 
1  
 
 
 
 
0.5 
 
 
 
0.25 
 
 
 
0.125 
 
 
 
0.062 
 
 
 
0.0315 
 
 
 
0.016 
 
 
 
 
2.2.7 Plax (sodium fluoride and triclosan) 
Seven double dilutions of commercially available Plax were prepared.  The 
concentrations of fluoride in each dilution are shown in table 2.7.  Eight 
concentrations including the stock solution were studied. 
 
Table 2.7 Test concentrations of Plax 
 1 
 
Stoc
k 
solu. 
 
2 
 
5ml 
of 
stock 
+ 
 
5ml 
H2O 
3 
 
5ml  
of 
conc.
2      
+ 
5ml 
H2O 
4 
 
5ml  
of 
conc.
3 
+ 
5ml 
H2O 
5 
 
5ml  
of 
conc.
4 
+ 
5ml 
H2O 
6 
 
5ml  
of 
conc. 
5 
+ 
5ml 
H2O 
7 
 
5ml  
of 
conc. 
6 
+ 
5ml 
H2O 
8 
 
5ml  
of 
conc. 
7 
+ 
5ml 
H2O 
Fluoride 
mg/ml 
Triclosa
n 
mg/ml 
 
0.02
5 
 
0.03 
 
0.01
2 
 
0.01
5 
 
0.006 
 
 
0.008 
 
0.003 
 
 
0.004 
 
0.001 
 
 
0.002 
 
0.000
8 
 
0.001 
 
0.000
4 
 
0.000
5 
 
0.000
2 
 
0.000
2 
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2.3    Minimum inhibitory concentration (MIC) test procedure 
The minimum inhibitory concentration test was done for all the chemicals 
using microtitre plates and the test organisms described in section 2.1, in the 
test concentrations described in tables 2.1 to 2.7.  One hundred microlitres of 
each test concentration was added to 100 µl inoculum (section 2.1) and was 
placed into 8 wells.  Control wells were prepared by adding 100 µl of 
inoculum to 100 µl of sterile distilled water.  
The minimum concentration of glycerine that inhibited microbial growth was 
mixed with sodium fluoride and potassium nitrate to make up the experimental 
mouthrinse.  7g of Potassium nitrate, 0.025g of sodium fluoride was added 
into 70ml of sterile distilled water. Once the solutes were dissolved, 30ml of 
glycerine was added.  This mixture was taken as the stock solution. Seven 
serial ½ dilutions were then prepared, and eight concentrations including the 
stock solution were used, table 2.8. 
 
     Table 2.8 Test concentrations of the experimental mouthrinse 
 
Mixture 
 
Stock 
 
5ml  
+ 
5ml 
H2O 
 
5ml  
+ 
5ml 
H2O 
 
5ml  
+ 
5ml 
H2O 
 
5ml  
+ 
5ml 
H2O 
 
5ml  
+  
5ml 
H2O 
 
5ml  
+ 
5ml 
H2O 
 
5ml  
+ 
5ml 
H2O 
 
Gly* 
NaF 
KNO3 
 
30 
0.025 
7 
 
15 
0.0125 
3.5 
 
7.5 
0.0063
1.75 
 
3.25 
0.0032
0.875 
 
1.625 
0.0016
0.4375
 
0.812 
0.0008
0.2188
 
0.406 
0.0004 
0.1094 
 
0.203 
0.0002 
0.0547 
                 *Percentage 
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For the commercial mouthrinses (Corsodyl and Plax) and the experimental 
mouthrinse the first wells were prepared by adding 180 µl of the concentration 
and 20 µl of inoculum.  The final test concentration in each well was 
calculated in the following manner: 
 
Concentration added into the well ÷ 2 = final concentration into the well (table 
2.9). 
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Table 2.9 Final concentrations of test chemicals into each well after adding the 
inoculum of C. albicans (in SAB), S. aureus and S. mutans (in NB) respectively. 
Test 
chemical 
Well 1 Well 2 Well 3 Well 4 Well 5 Well 6 Well 7 Well 8 
Alum  
 
 
Inoculum 
100ul 
0.25M 
+  
100ul   
100ul 
0.19M 
+ 
100ul  
100ul 
0.14M 
+  
100ul 
 
100ul 
0.11M 
+ 
 100ul 
 
100ul 
0.08M 
+ 
 100ul 
 
100ul 
0.06M 
+  
100ul 
 
100ul 
0.04M 
+  
100ul 
 
100ul 
0.03M 
+ 
100ul 
 
Conc*  0.125 0.094 0.071 0.053 0.040 0.030 0.022 0.017 
Glycerine 
 
 
 
Inoculum 
100ul 
100% 
solu. 
+  
100ul 
100ul  
80% 
solu. 
+  
100ul 
100ul 
70% 
Solu. 
+  
100ul 
100ul 
60% 
Solu. 
+  
100ul 
100ul 
50% 
Solu. 
+  
100ul 
100ul 
40% 
Solu. 
+  
100ul 
100ul 
30% 
Solu. 
+  
100ul 
100ul 
20% 
Solu. 
+  
100ul 
Conc**  50 40 35 30 25 20 15 10 
Salt 
 
 
Inoculum 
100ul 
6M  
+  
100ul 
100ul 
4.5M  
+  
100ul 
100ul 
3.38M  
+  
100ul  
100ul 
2.53M 
+  
100ul 
100ul 
1.90M 
+  
100ul 
100ul 
1.42M 
+  
100ul 
100ul 
1.07M 
+  
100ul 
100ul 
0.80M 
+  
100ul 
Conc.*  3 2.25 1.69 1.27 0.95 0.71 0.53 0.40 
KNO3 
 
 
 
Inoculum 
100ul 
7% 
solu. 
+ 
100ul 
100ul  
3.5% 
solu. 
+ 
100ul 
100ul 
1.75% 
Solu. 
+ 
100ul 
100ul 
0.875%
Solu 
+ 
100ul 
100ul 
0.438%
Solu 
+ 
100ul 
100ul 
0.219%
Solu 
+ 
100ul 
100ul 
0.109%
Solu 
+ 
100ul 
100ul 
0.054%
Solu 
+ 
100ul 
Conc**  3.5 1.75 0.875 0.438 0.219 0.109 0.054 0.027 
NaF 
 
 
 
Inoculum 
100ul 
0.025% 
solu. 
+ 
100ul 
100ul  
0.012% 
solu. 
+ 
100ul 
100ul 
0.006% 
Solu. 
+ 
100ul 
100ul 
0.003%
Solu 
+ 
100ul 
100ul 
0.001%
Solu 
+ 
100ul 
100ul 
0.0008
%Solu 
+ 
100ul 
100ul 
0.0004
%Solu 
+ 
100ul 
100ul 
0.0002
%Solu 
+ 
100ul 
Conc**  0.012 0.006 0.003 0.001 0.0008 0.0004 0.0002 0.0001 
Commercial 
 (Corsodyl) 
 
 
 
Inoculum 
 
180ul  
2  
mg/ml 
+ 
20ul 
 
100ul 
2  
mg/ml 
+ 
100ul 
 
100ul  
1  
mg/ml 
 + 
100ul  
1 
100ul 
0.5 
mg/ml 
 + 
100ul 
 
100ul 
0.25 
mg/ml 
+ 
100ul 
 
100ul 
0.13 
mg/ml 
+ 
100ul 
 
100ul 
0.06 
mg/ml 
+ 
100ul 
 
100ul 
0.03 
mg/ml 
+ 
100ul 
Conc.  g 2 1 0.5 0.25 0.13 0.06 0.03 0.02 
Commercial 
Plax 
Fluoride 
 
Triclosan 
 
 
Inoculum 
 
180ul  
0.025  
mg/ml 
0.03  
mg/ml 
+ 
20ul  
 
100ul 
0.025  
mg/ml 
0.03  
mg/ml 
+ 
100ul 
 
100ul 
0.012 
 mg/ml 
0.015 
mg/ml 
+ 
100ul 
 
100ul 
0.006  
mg/ml 
0.008  
mg/ml 
+ 
100ul 
 
100ul 
0.003 
mg/ml 
0.004 
mg/ml 
+ 
100ul 
 
100ul 
0.001 
mg/ml 
0.002 
mg/ml 
+ 
100ul 
 
100ul 
0.0008 
mg/ml 
0.001 
mg/ml 
+ 
100ul 
 
100ul 
0.0004 
mg/ml 
0.0005 
mg/ml 
+ 
100ul 
Concg    
Fluoride 
Triclosan 
 
0.025 
0.03 
 
0.012 
0.015 
 
0.006 
0.008 
 
0.003 
0.004 
 
0.001 
0.002 
 
0.0008 
0.001 
 
0.0004 
0.0005 
 
0.0002 
0.0002 
*Molar;  **Percentage;      g mg/ml  
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The microtitre plates of C. albicans and S. aureus were incubated aerobically 
and S. mutans under CO2  at 37o C for 24 hours.  Each well was subcultured for 
the presence of surviving test microorganisms using the appropriate medium 
(section 2.1). The culture plates were further incubated at 37o C for 24 hours.  
The minimum dilution (concentration) with absence of any test organism was 
recorded as the MIC.  Each experiment was repeated three times. 
 
2.4 Time-Kill study procedure 
2.4.1 The number of  organisms challenged 
Inoculums were prepared by suspending C. albicans in SAB, and S. aureus 
and S. mutans in NB.  The exact number of organisms challenged was 
calculated in the following way:  twenty microlitres of the inoculum was 
serially diluted ten fold to 10-1, 10-2, and 10-3;  20µl was then taken from these 
dilutions and was plated on the appropriate agar plate.  The culture plates were 
incubated at 37oC for 48 hours, after which colonies were counted, the number 
of organisms was determined and this number was taken as the challenged 
organisms.  
 
2.4.2 Time-kill experimental procedure 
In the time and percentage kill experiment, 5ml of the experimental mixture 
(containing 30% glycerine, 7g potassium nitrate, 0.025g sodium fluoride and 
70ml of water), was inoculated with 100µl of the inoculum.  Every 60 seconds 
for 3 minutes, 20µl of the inoculated test compound was removed and mixed 
with 20µl of the universal neutralizer.  20µl of neutralised mixture was then 
micro-diluted to 10-1, 10-2, 10-3 and 10-4 and spread onto an appropriate 
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medium; C. albicans on SAB, S. aureus on TA and S. mutans on BA. Culture 
plates for C. albicans and S. aureus were incubated aerobically and S. mutans 
under CO2 at 37oC for 48 hours.  The colony count for each plate was 
determined and the percentage kill was calculated using the challenged 
organism count.  The percentage of the challenged minus surviving organisms 
was taken as the number of microorganisms killed. 
 
Percentage killed = challenged organisms-surviving organisms x 100  
                                                        Challenged organisms 
 
 
The percentage kill was performed three times with all three strains. 
 
The results of the experimental mouthrinse were compared with Corsodyl and 
Plax using the Chi-square test.  The results of Corsodyl and Plax were also 
compared using the same test. 
 
 
2.5 Cost comparison 
The cost of the three chemicals included into the experimental mouthrinse 
were compared with the costs of the equivalent amounts of the commercially 
available mouthrinses (Corsodyl®  and Plax®)  
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3 RESULTS 
                                                           
3.1 Minimum inhibitory concentration (MIC) of test compounds 
for C. albicans 
 
The results are shown in table 3.1. Alum, Salt and KNO3 had no effect even at 
the highest concentrations.  Glycerine on the other hand and Corsodyl® 
inhibited C. albicans growth at all concentrations.  Plax® which had a mixture 
of fluoride and triclosan inhibited growth at 0.001 and 0.002 mg/ml 
respectively.  
Table 3.1 Minimum inhibitory concentration (MIC) of test compounds for C. 
albicans; + indicates growth and – indicates inhibition of growth. 
                    Microtitre plate Test 
chemicals 
Test 
runs Well 
1 
Well 
2 
Well 
3 
Well 
4 
Well 
5 
Well 6 Well 7 Well 8 
1 + + + + + + + + 
2 + + + + + + + + 
Alum   
 
3 + + + + + + + + 
Conc*   0.125 0.094 0.071 0.053 0.04 0.03 0.022 0.017 
1 - - - - - - - - 
2 - - - - - - - - 
Glycerine 
 
3 - - - - - - - - 
Conc **  50 40 35 30 25 20 15 10 
1 + + + + + + + + 
2 + + + + + + + + 
Salt  
 
3 + + + + + + + + 
Conc *  3 2.25 1.69 1.27 0.95 0.71 0.53 0.40 
1 + + + + + + + + 
2 + + + + + + + + 
KNO3  
 
3 + + + + + + + + 
Conc**  7 3.5 1.75 0.875 0.438 0.219 0.109 0.055 
1 + + + + + + + + 
2 + + + + + + + + 
NaF  
 
3 + + + + + + + + 
Conc **  0.025 0.013 0.006 0.003 0.002 0.001 0.0005 0.0003 
1 - - - - - - - - 
2 - - - - - - - - 
Corsodyl®  
 
3 - - - - - - - - 
Concg     2 1 0.5 0.25 0.125 0.06 0.032 0.016 
1 - - - - - + + + 
2 - - - - - + + + 
Plax®  
 
3 - - - - - + + + 
Concg  
Fluoride 
Triclosan 
  
0.025 
0.03 
 
0.012 
0.015 
 
0.006 
0.008 
 
0.003 
0.004 
 
0.001 
0.002 
 
0.0008 
0.001 
 
0.0004 
0.0005 
 
0.0002 
0.0002 
 
*   Molar, **  Percentage,  gmg/ml  
  
 27
3.2 MIC of test compounds for S. aureus 
 
The results on table 3.2 show that Alum inhibited the growth of S. aureus from 
a concentration of 0.094M and glycerine from 30%.  Salt, KNO3 and NaF had 
no antimicrobial effect on S. aureus.  Corsodyl® and Plax® inhibited S. 
aureus at all concentrations.  
Table 3.2 MIC of test compounds for S. aureus; +indicates growth and – 
indicates inhibition of growth. 
                         Microtitre plate Test 
Chemicals 
Test 
runs Well 
1 
Well 
2 
Well 
3 
Well 
4 
Well 
5 
Well 6 Well 7 Well 8 
1 - - + + + + + + 
2 - - + + + + + + 
Alum   
 
3 - - + + + + + + 
Conc *  0.125 0.094 0.071 0.053 0.04 0.03 0.022 0.017 
1 - - - - - + + + 
2 - - - - + + + + 
Glycerine 
 
3 - - - - - - + + 
Conc **  50 40 35 30 25 20 15 10 
1 + + + + + + + + 
2 + + + + + + + + 
Salt  
 
3 + + + + + + + + 
Conc *  3 2.25 1.69 1.27 0.95 0.71 0.53 0.40 
1 + + + + + + + + 
2 + + + + + + + + 
KNO3  
 
3 + + + + + + + + 
Conc**  7 3.5 1.75 0.875 0.438 0.219 0.109 0.055 
1 + + + + + + + + 
2 + + + + + + + + 
NaF  
 
3 + + + + + + + + 
Conc **  0.025 0.013 0.006 0.003 0.002 0.001 0.0005 0.0003 
1 - - - - - - - - 
2 - - - - - - - - 
Corsodyl®  
 
3 - - - - - - - - 
Conc g  2 1 0.5 0.25 0.125 0.062 0.032 0.016 
1 - - - - - - - - 
2 - - - - - - - - 
Plax®  
 
3 - - - - - - - - 
Concg  
Fluoride 
Triclosan 
  
0.025 
0.03 
 
0.012 
0.015 
 
0.006 
0.008 
 
0.003 
0.004 
 
0.001 
0.002 
 
0.0008 
0.001 
 
0.0004 
0.0005 
 
0.0002 
0.0002 
 
   *Molar  **Percentage  gmg/ml  
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3.3     MIC of test compounds for S. mutans 
 
 The results from table 3.3 show that Alum, KNO3 and NaF had no effect on S. 
mutans. Salt inhibited the growth of S. mutans from a concentration of 1.69M.  
Glycerine and Corsodyl®  inhibited the growth at all concentrations and Plax 
(containing fluoride and triclosan) inhibited the growth from 0.0004mg/ml and 
0.0005mg/ml respectively.      
Table 3.3 MIC of test compounds for S. mutans; +indicates growth and –
indicates inhibition of growth.  
 Test 
chemicals 
Test 
runs Well 
1 
Well 
2 
Well 
3 
Well 
4 
Well 
5 
Well 6 Well 7 Well 8 
1 + + + + + + + + 
2 + + + + + + + + 
Alum   
 
3 + + + + + + + + 
Conc *  0.125 0.094 0.071 0.053 0.04 0.03 0.022 0.01 
1 - - - - - - - - 
2 - - - - - - - - 
Glycerine 
 
3 - - - - - - - - 
Conc **  50 40 35 30 25 20 15 10 
1 - - + + + + + + 
2 - - - + + + + + 
Salt  
 
3 - - - + + + + + 
Conc *  3 2.25 1.69 1.27 0.95 0.71 0.53 0.40 
1 + + + + + + + + 
2 + + + + + + + + 
KNO3  
 
3 + + + + + + + + 
Conc **  7 3.5 1.75 0.875 0.438 0.219 0.109 0.055 
1 + + + + + + + + 
2 + + + + + + + + 
NaF  
 
3 + + + + + + + + 
Conc**  0.025 0.013 0.006 0.003 0.002 0.001 0.0005 0.0003
1 - - - - - - - - 
2 - - - - - - - - 
Corsodyl®  
 
3 - - - - - - - - 
Concg   2 1 0.5 0.25 0.125 0.062 0.032 0.016 
1 - - - - - - - + 
2 - - - - - - - + 
Plax ® 
 
3 - - - - - - - + 
Concg 
Fluoride 
Triclosan 
  
0.025 
0.03 
 
0.012
0.015
 
0.006
0.008
 
0.003
0.004
 
0.001
0.002
 
0.0008
0.001 
 
0.0004 
0.0005 
 
0.0002
0.0002
*Molar;  **Percentage ;   gmg/ml 
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3.4 MIC of the test compounds on the test organisms 
Table 3.4 shows that Alum inhibited the growth of C. albicans, S. aureus and 
S. mutans at the median concentrations shown.   Glycerine inhibited the 
growth of C. albicans and S. mutans at concentration <10%.  Salt did not have 
antimicrobial properties against C. albicans and S. aureus but it had 
anitimicrobial properties against S. mutans at the concentration of 1.69M.  
KNO3 and NaF did not have any antimicrobial properties against any of the 
test organisms.  
 
 
   
        Table 3.4 Median MICs of the test compounds on the test organisms 
 
Strain Chemical Median 
(n=3) 
Alum (M) >0.125M 
Glycerine (%) <10% 
Salt (M) >3M 
KNO3 (%) >7% 
C. 
albicans 
NaF (%) >0.025% 
Alum (M) 0.094M 
Glycerine (%) 25% 
Salt (M) >3M 
KNO3 (%) >7% 
S. aureus 
 
NaF (%) >0.025% 
Alum (M) >0.125M 
Glycerine (%) <10% 
Salt (M) 1.69M 
KNO3 (%) >7% 
S. mutans 
NaF (%) >0.025% 
        M= Molar 
        %= Percentage     
 
3.5 The MICs of the mouthrinses on the test organisms  
Table 3.5 Shows the median minimum inhibitory concentration of the 
experimental mouthrinse compared with the commercially available 
mouthrinses.   These figures were identical for each compound and each test.  
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Table 3.5 Median MICs of the mouthrinses on test organisms 
 
Strain Chemical Median 
(n=3) 
Experimental 
mouthrinse 
(Glycerine**  
KNO3* + 
+NaF*)   
 
 
7.5 
0.006 
1.75 
Corsodyl® 
(mg/ml) 
<0.016 
C. albicans 
Plax – fluoride 
(mg/ml)- triclosan 
0.001 
0.002 
Experimental 
mouthrinse 
(Glycerine** +  
KNO3* 
+NaF*)   
 
 
15 
0.012 
3.5 
Corsodyl® 
(mg/ml) 
<0.016 
S. aureus 
 
Plax – fluoride 
(mg/ml)- triclosan 
<0.0002 
<0.0002 
Experimental 
mouthrinse 
(Glycerine** +  
KNO3* + 
NaF*)   
 
 
7.5 
0.006 
1.75 
Corsodyl® 
(mg/ml) 
<0.016 
S. mutans 
Plax® – fluoride 
(mg/ml)- triclosan 
0.0004 
0.0005 
              * Molar 
              ** Percentage 
 
3.6 Percentage of test organisms killed by the experimental 
mouthrinse and two commercially available mouthrinses. 
 
 Figures 3.1, 3.2 and 3.3 show the percentages of the test organisms killed by 
the experimental mouthrinse and the two commercially available mouthrinses 
after 1 min, 2min and 3min respectively.  The statistical analysis, however, 
showed no significant differences between all three mouthrinses.  
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Figure 3.1 Percentage of C. albicans killed in 1, 2 and 3 minutes by the  
experimental mouthrinse, Corsodyl® and Plax®. 
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Figure 3.2 Percentage of S. aureus killed in 1, 2 and 3 minutes by the 
experimental mouthrinse, Corsodyl® and Plax®. 
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Figure 3.3 Percentage of S. mutans killed in 1, 2 and 3 minutes by the 
experimental mouthrinse, Corsodyl® and Plax®. 
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3.7 The chi-squared results of the experimental mouthrinse and 
the two commercially available mouthrinses. 
 
The ability of the experimental mouthrinse to kill the three test organisms after 
1 min, 2 min and 3 min respectively was compared to the two commercially 
available mouthrinses using the chi-squared test and the results showed no 
significant differences between the mouthrinses (Table 3.6). 
Table 3.6 Comparison of percentage kill over time between mouthrinses 
for all organisms.  All values are chi-squared results at P<0.05. 
 
 Experimental 
mouthrinse 
Corsodyl Plax 
Experimental 
Mouthrinse 
                    1min 
                       2min 
                       3min 
  
 
0.09 
0.18 
0.66 
 
 
0.06 
0.17 
0.66 
Corsodyl®    1min 
                       2min 
                       3min  
  0.97 
0.99 
0.99 
Plax®            1min 
                       2min 
                       3min 
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3.8 Cost comparison  
 
Table 3.7 shows that the experimental mouthrinse was cheaper than the 
commercial  mouthrinses. It cost R5.24/100ml including the bottle whereas 
Corsodyl® cost R30.00/100ml and Plax® cost R10.00/100ml. 
 
 
Table 3.7 Cost comparison of experimental mouthrinses as at December, 
2006 
 
Mouthrinse Chemical Cost: R Cost: R/100ml 
KNO3 17.50/kg 
NaF 7.77/kg 
Experimental 
mouthrinse 
Glycerine 174.65/l 
 
5.24 
Corsodyl®    30.00 
Plax®   10.00 
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4. DISCUSSION       
 
4.1 Selection of test organisms 
C. albicans, a normal oral commensal, is the most frequently isolated yeast 
from oral infections.  In South Africa it has been shown that 81% of HIV 
positive and 63% of HIV negative patients were C. albicans carriers (Patel, 
Shackleton & Coogan, 2006).  The most common oral infection caused by C. 
albicans is an oral candidiasis and it affects immunocompromised patients 
such as those who are HIV positive, organ transplant and cancer patients, 
particularly those on radiation therapy.  
 
S. aureus is a gram positive coccus, is a potential pathogen, and may be 
carried asymptomatically in the nasopharynx of up to 40 % of individuals.  It 
does not usually play a significant role in intraoral infections but may cause 
serious infections associated with accidental or surgically induced wounds 
(Smith, et al., 2001).  
 
S. mutans is implicated in dental caries. It is an acidogenic and aciduric oral 
commensal which produces acids and extracellular polysaccharides from 
fermentable carbohydrates. One of the problems encountered by cancer 
patients with radiation therapy is the development of dental caries.  Epstein, 
McBride and Stevenson-Moore (1991) showed that 66% of their patients 
treated with radiation therapy had high levels of S. mutans.  Meng, Liu and 
Peng, (2005) showed that there is a persistence of S. mutans in nasopharyngeal 
carcinoma patients after radiotherapy, mostly due to the poor oral hygiene 
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prevalent in cancer patients.  This poor oral hygiene may be due to painful 
open wounds, and this leads to an increase in S. mutans levels.    
 
4.2 C. albicans and the test chemicals 
C. albicans was eliminated by glycerine at a concentration of 10% (table 3.1).   
Hexylene glycol has been shown to have antifungal properties (Kinnunen and 
Koskela, 1991), is nontoxic, water soluble, and can be used as an humectant 
(Hodosh et al. 2004) as well as an antimicrobial compound.  
 
Previous studies have shown that Alum can prevent dental caries (Kleber, et 
al. 1996) by increasing the salivary pH thus neutralising acids produced by 
bacteria and acidogenic food. In this study the anticandida activity was 
investigated, and it was found that there was none.  
 
Salt is known to aid in the formation of granulation tissue and to promote 
healing (Daeffler, 1981 cited by Dodd et al. 2003).  Incorporation of this 
compound in the experimental mouthrinse was for its mucolytic properties and 
not as an anticandida compound, so the lack of any anticandida activity was 
not unexpected.  
 
Similarly potassium nitrate also displayed no anticandida activity, but its 
inclusion was as an analgesic compound. 
 
Sodium fluoride did not show any anticandida activity.  It is known to have 
antifungal activity at very high concentrations such as 10-20 mg/ml (Ates, 
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Akdeniz and Sen, 2005) whereas in this study only 0.25mg/ml was used, as a 
fluoride source for the prevention of dental caries and not as an antifungal 
agent.  
 
Corsodyl® and Plax® showed good anticandida activity.  Corsodyl is 
commonly used for the treatment of oral candidiasis together with antifungal 
agents.  Its antifungal activity is well established (McGaw and Belch, 1985; 
Epstein, 1992).  Plax, although used mainly as an antiplaque agent, also 
showed antifungal activity in this study.  Plax is a mixture of NaF and 
triclosan.  As the study has shown that NaF did not have any antifungal 
activity, it is probable that triclosan was responsible.  This is confirmed by 
studies that have shown that triclosan has both antifungal and antibacterial 
properties (Giuliana et al. 1997). 
 
4.3 S. aureus and the test chemicals 
Sodium chloride, KNO3 and NaF did not have any effect on S. aureus (table 
3.2). These chemicals were included in this study for other purposes as 
discussed above.  Alum on the other hand killed S. aureus even at a 
concentration as low as 0.094 M. A higher concentration of glycerine was 
required to kill S. aureus (25%) compared to C. albicans (10%).  
 
Corsodyl® and Plax® gave similar results against for C. albicans.  Both 
compounds proved to have good antifungal and antibacterial properties. 
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4.4 S. mutans and the test chemicals 
S. mutans proved to be the easiest organism to kill compared with the other 
two test organisms (table 3.3). Alum and salt even at a very low concentration 
(0.01M and 1.69M respectively) eliminated S. mutans.  Potassium nitrate and 
NaF once again had no effect. Although Plax showed anti S. mutans activity, 
NaF alone did not kill S. mutans.  Glycerine proved to be the best chemical 
tested for the elimination of S. mutans doing so at a concentration as low as 
10%. 
 
Corsodyl® and Plax® once again showed good anti S. mutans activity. 
Chlorhexidine gluconate is an extensively used member of the bisbiguanide 
group of antimicrobial compounds.  
 
4.5     Selection of chemicals for the experimental mouthrinse 
From the above results and from the literature, it was clear that certain 
chemicals can be used as antimicrobial, lubricant, anticaries, mucolytic, or 
analgesic agents.  
 
4.5.1 Alum 
It was decided to exclude alum from the experimental mouthrinse for a variety 
of reasons.  Kleber and Putt (1994) showed that alum reduced enamel 
dissolution from approximately 10% after a single 5 min exposure to nearly 
90% after a total cumulative treatment time of 100 min.  It is not practical to 
expect patients to hold a mouthrinse in the mouth for 5 minutes at a time.  
Olmez et al. (1998) showed that the mean plaque and salivary levels of S. 
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mutans were significantly reduced after two weeks.  In this study Alum 
eliminated S. aureus and S. mutans but so did glycerine. Alum crystallized out 
when it was added to a solution that had Potassium nitrate and hexylene 
glycol.  The other reason that led to the decision to leave out alum is that the 
study carried out by Putt and Kebler (1986) showed that alum solution was 
most effective when used in concentrations greater than 0.005mol/L in the pH 
range 3.5-4.5 and for exposure greater than 4 min, whereas the recommended 
exposure time of the experimental mouthrinse is going to be 1 min; it was 
considered impractical to assume patient compliance for a 4-minute rinse.  
 
4.5.2 Glycerine 
Glycerine is used as an humectant and as an antimicrobial agent. Kinnunen 
and Koskela (1991) showed that 10% hexylene glycol killed C. albicans, 
S.aureus and S. pyogenes.  In this study similar results were obtained, and so 
glycerine was selected as a main compound for the experimental mouthrinse. 
 
4.5.3 Sodium Chloride 
Salt displayed minimal antibacterial property. It was meant to be used for its 
mucolytic property and enhancement of taste.  Saline solution is also thought 
to aid in the formation of granulation tissue and to promote healing (Dodd, 
Dibble and Miaskowski, 2000).  However, salt does not mix with hexylene 
glycol and potassium nitrate; therefore it was excluded from the experimental 
mouthrinse.  
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4.5.4 Potassium nitrate 
Cancer patients also develop soft tissue necrosis, oral infections and painful 
mucositis, all of which cause difficulty in talking and eating.  An analgesic 
compound incorporated into their oral care regimen would therefore be 
beneficial.  In this study KNO3 did not show any antimicrobial activity but it is 
known to have an analgesic effect and therefore it was decided to incorporate 
it into the experimental mouthrinse.  Gillam et al. (1996) showed that rinsing 
twice daily with a 3% KNO3/Silica/NaF mouthrinse compared with Silica/NaF 
control resulted in reduced discomfort from cervical dentine sensitivity when 
evaluated by tactile and thermal stimuli.  
 
Potassium nitrate has also been used in a gel form to treat aphthous ulcers 
(Hodosh, et al., 2004).  It is also possible that the compliance of using NaF is 
decreased because of the pain that is caused by open wounds as inserting 
custom trays in the mouth with open wounds can be extremely painful, 
therefore incorporating KNO3  will  also help to solve this problem.  
 
4.5.5 Sodium Fluoride 
The use of topical fluoride to reduce caries has become the standard of care for 
patients undergoing radiotherapy, but compliance has been reported as 
generally being poor because the patient is expected to apply it using trays 
which are supposed to be left sometimes for as long as five minutes (Andrews 
and Griffiths, 2001; Epstein, et al. 1996).  Sodium fluoride if incorporated into 
a mouthrinse will be highly beneficial. Although sodium fluoride did not show 
any antimicrobial properties, it promotes remineralisation of the enamel, 
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(Marsh and Martin, 1999) decreases the rate of sugar uptake and acid 
production by plaque bacteria, as well as reduces extracellular polysaccharide 
production.  This means that sodium fluoride can reduce development of 
dental caries in many ways without showing any antimicrobial effects.  An 
effective concentration (0.025 mg/ml) of sodium fluoride was therefore 
incorporated into the experimental mouthrinse. 
 
4.6 The experimental mouthrinse 
The experimental mouthrinse contained glycerine as an antimicrobial and 
humectant, potassium nitrate as an analgesic and sodium fluoride as a caries 
controlling agent. Mixing these three ingredients did not affect the 
antimicrobial property of glycerine (table 3.6).  MIC results of this 
experimental mouthrinse showed that even if it is diluted 4 to 8 times it will be 
effective against all three test organisms.  
 
The efficacy of a mouthrinse depends on the effective concentration of its 
active ingredients, the effectiveness of all the compounds and the time 
required to achieve the target factors.  In this study the first phase established 
the first two factors and the second phase established the time required to 
eliminate the test microorganisms.  This study was carried out for one, two, 
and three minutes to examine the percentage of test organisms killed.  
However, results of one minute are most relevant because patients normally do 
not hold the solution in their mouth for long.  If they are advised to hold the 
solution in their mouths for a longer time period, the patient compliance will 
not be good.  In one minute, the experimental mouthrinse was most effective 
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against C. albicans (99.78% kill), which is the most common causative agent 
of oral candidiasis, especially in cancer patients who undergo radiation 
therapy.   
 
Sixty two percent of S. aureus was killed within a minute of exposure to the 
experimental mouthrinse.  Large numbers of S. aureus are found in the saliva 
of healthy older subjects (Samaranayake, 2002) and in the oral cavity it can 
infect open wounds.  The experimental mouthrinse has the capacity to reduce 
the numbers of S. aureus which can therefore reduce the chances of S. aureus 
infection in cancer patients.  
 
Ninety two percent of S. mutans was killed within 1 minute of exposure to the 
experimental mouthrinse.  Reduction in the number of these bacteria in the 
mouth will reduce plaque formation and hence caries formation.  Cancer 
patients are often in pain and their oral hygiene is not adequate. Reduction of 
saliva can also make them more susceptible to caries formation.  
 
The experimental mouthrinse demonstrated an appropriate antimicrobial 
effect, has the capacity to alleviate pain from open mucosa lesions and to 
decrease carious lesion formation.  It will certainly be easier for clinicians who 
have to construct obturators and dentures for these patients to take impressions 
without causing too much pain or traumatising the already traumatised and 
infected mucosa.  The speedy recovery of the abused tissues and minimising 
of infection is of paramount importance 
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4.7 Comparison of the experimental mouthrinse to the commercial 
mouthrinses 
 
4.7.1 Efficacy 
The results showed that after one minute of exposure to both the experimental 
and commercial mouthrinses, most of the challanged C. albicans were killed 
(Figure 3.1). Corsodyl® killed slightly less C. albicans when compared to the 
experimental mouthrinse and Plax®.  In two and three minutes the percentage 
of killed C. albicans was similar for all three mouthrinses. When S. aureus 
was exposed to all three mouthrinses for 1 minute, 2 minutes and three 
minutes, the percentage killed  by the experimental mouthrinse as compared to 
the two commercially available mouthrinses was far less. Both Corsodyl® and 
Plax® showed similar results. When S. mutans was exposed to the 
experimental mouthrinse for 1 minute, the percentage kill was lower than the 
commercial mouthrinses, however after 2 minutes and 3 minutes it killed a 
similar percentage compared to the commercially available mouthrinses. Both 
commercially available mouthrinses do not have pain relieving compounds 
and these mouthrinses can not act as an humectant. Even though the 
percentage kill of S. aureus was far less than both the commercially available 
mouthrinses after 1 min, the chi squared results showed no statistically 
significant difference.  
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4.7.2 Cost  
Chlorhexidine digluconate cannot be obtained over the counter without a 
prescription. Plax® on the other hand can be obtained without a prescription but 
may be too expensive for the lower income earners of the community. The 
experimental mouthrinse costs R5.24 for a bottle of 100ml whereas Corsodyl® 
costs R30.00 and Plax® costs R10.00. It contains an analgesic that both 
commercial mouthrinses do not have. Separate analgesics are usually prescribed 
for patients with open wounds thus increasing the cost of treating such patients. 
The experimental mouthrinse incorporates an analgesic which may obviate the 
need for additional medication thus further reducing the costs.  
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5 CONCLUSION       
A mouthrinse effective in relieving oral symptoms in patients receiving 
radiation therapy needs to show some antimicrobial activity against C. 
albicans, S. mutans and S. aureus, whilst at the same time having an 
humectant and palliative effect.  It would seem that the experimental 
mouthrinse shows promise in fulfilling these requirements. 
 
Sucralose could be added to enhance the taste, especially for young children. 
Sucralose is 600 times sweeter than sucrose.  It provides no energy, it is poorly 
absorbed and it is excreted unchanged from the body.  It is also heat stable 
(ADA report, 2004).  Bowen, Young and Pearson (1990) showed that 
sucralose is non-cariogenic in rats.  The mouthrinse efficacy will then have to 
be tested with added sucralose to test whether sucralose will affects its 
antimicrobial properties. If it does not, then cytotoxicity tests will also be 
required.   
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